Compugen Announces Discovery of Two Drug Target Candidates for mAb Cancer Therapy

News   Mar 05, 2013

 
Compugen Announces Discovery of Two Drug Target Candidates for mAb Cancer Therapy
 
 
 
 

RELATED ARTICLES

Hypothalamic Stem Cells Control Speed of Ageing

News

Researchers have found that stem cells in the brain’s hypothalamus govern how fast aging occurs in the body, which could lead to new strategies for warding off age-related diseases and extending lifespan.

READ MORE

Bioinformatics to Help Understand Intrinsically Disordered Proteins

News

Over the last several decades, scientists have sequenced 85 million unique proteins, structured and unstructured alike, but still don’t know what the vast majority of these proteins do.

READ MORE

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE